Enovis Corp. (ENOV)
25.74
+0.49
(+1.94%)
USD |
NYSE |
May 19, 16:00
25.74
0.00 (0.00%)
After-Hours: 20:00
Enovis Research and Development Expense (Quarterly) : 31.53M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | 18.69M |
| Globus Medical, Inc. | 36.51M |
| Abbott Laboratories | 767.00M |
| AngioDynamics, Inc. | 7.084M |
| Accuray, Inc. | 8.178M |